Citigroup Inc Trans Medics Group, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Citigroup Inc holds 42,076 shares of TMDX stock, worth $3.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,076

Previous 9,524 341.79%

Holding current value

$3.41 Million

Previous $1.43 Million 360.6%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$135.68 - $176.11 $4.42 Million - $5.73 Million	32,552 Added 341.79%	42,076 $6.61 Million
Q2 2024 Aug 12, 2024	BUY	$72.62 - $150.62 $275,229 - $570,849	3,790 Added 66.1%	9,524 $1.43 Million
Q1 2024 May 10, 2024	SELL	$70.86 - $89.93 $399,508 - $507,025	-5,638 Reduced 49.58%	5,734 $423,000
Q4 2023 Feb 09, 2024	BUY	$36.74 - $81.08 $161,288 - $355,941	4,390 Added 62.88%	11,372 $897,000
Q3 2023 Nov 09, 2023	SELL	$53.47 - $96.07 $297,988 - $535,398	-5,573 Reduced 44.39%	6,982 $382,000
Q2 2023 Aug 10, 2023	BUY	$66.23 - $88.73 $676,605 - $906,465	10,216 Added 436.77%	12,555 $1.05 Million
Q1 2023 May 11, 2023	BUY	$53.63 - $82.33 $60,816 - $93,362	1,134 Added 94.11%	2,339 $177,000
Q4 2022 Feb 09, 2023	BUY	$39.08 - $64.29 $312 - $514	8 Added 0.67%	1,205 $74,000
Q3 2022 Nov 10, 2022	SELL	$31.56 - $55.75 $37,935 - $67,011	-1,202 Reduced 50.1%	1,197 $50,000
Q2 2022 Aug 10, 2022	BUY	$20.56 - $32.15 $13,775 - $21,540	670 Added 38.75%	2,399 $75,000
Q1 2022 May 12, 2022	SELL	$12.58 - $26.94 $66,724 - $142,889	-5,304 Reduced 75.42%	1,729 $47,000
Q4 2021 Feb 10, 2022	BUY	$19.16 - $32.68 $70,719 - $120,621	3,691 Added 110.44%	7,033 $135,000
Q3 2021 Nov 10, 2021	BUY	$25.92 - $34.51 $86,624 - $115,332	3,342 New	3,342 $111,000

Others Institutions Holding TMDX

# of Institutions

395

Shares Held

31.9M

Call Options Held

466K

Put Options Held

286K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.58B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account